Overview
Taisuke Uchida practices practicing medicine in Fukuoka, Japan.
Their clinical expertise encompasses Benign Chronic Pemphigus, Bullae, Osteoarthritis, and Arthritis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Taisuke Uchida
Is Taisuke Uchida a top-rated expert for Benign Chronic Pemphigus?
MediFind is an objective health platform that identifies experts based on real-world data. Taisuke Uchida is classified as an Experienced expert for Benign Chronic Pemphigus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Taisuke Uchida participate in research or clinical trials?
Yes. Taisuke Uchida has published 8 articles and abstracts on conditions like Benign Chronic Pemphigus. You can view a list of Taisuke Uchida's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ArthritisUchida isExperienced. Learn about Arthritis.
- Benign Chronic PemphigusUchida isExperienced. Learn about Benign Chronic Pemphigus.
- BullaeUchida isExperienced. Learn about Bullae.
- OsteoarthritisUchida isExperienced. Learn about Osteoarthritis.